ETIDIOH - NEW

Abstract The 1889 Russian (also called ‘Asiatic’) Flu epidemic can be described as one of the first modern pandemics . The development of extensive railroad and shipping networks during and prior to this period facilitated the previously unprecedented movement of goods and people around the world. It additionally propagated the process of shrinking the barriers between the countryside and major metropolises. While the COVID-19 pandemic resulted in lockdown measures nearly worldwide and prompted widespread social, economic, and cultural disruptions, the Russian Flu was not accompanied by such drastic changes. In this article, it is argued that the blunted historical consciousness of this epidemic were a result of a combination of factors , including the nascent state of scientific research and understanding of infectious diseases, the circumscribed reach of media, implicit comparisons to other contemporary epidemics, temporal closeness to the Spanish Flu and suppression of memory , and ...

Abstract Seasonal influenza continues to be a global health problem . Current existing vaccines and antivirals against influenza have limited effectiveness, and typically do not stay ahead of the viral evolutionary curve. Broad-spectrum antiviral agents that are effective therapeutically and prophylactically are much needed. We have created a promising new broad-spectrum anti-influenza agent using molecular engineering of a lectin from bananas , H84T, which is well-tolerated and protective in small animal models . However, the potency and effect of H84T on human immune cells and influenza-specific immune responses are undetermined. We found that H84T efficiently inhibited influenza A virus (IAV) replication in primary human dendritic cells (DCs) isolated from blood and tonsil, preserved DC viability and allowed acquisition and presentation of viral antigen. Excitingly, H84T-treated DCs subsequently initiated effective expansion of IAV-specific CD8 T cells. Furthermore, H84T preserved t...

Abstract Background .  Influenza A virus (IAV) is a major cause of morbidity and mortality globally , causing seasonal influenza in humans and infecting birds and some mammals. In 2024, IAV H5N1 highly pathogenic avian influenza (HPAI) in the United States moved into cattle. While the outbreak is currently of low risk to the general public, there is an urgent need to monitor the disease and prevent spread.  Methods .  We conducted a nationwide study evaluating the relationship between H5 hemagglutinin gene RNA concentrations in wastewater and reported outbreaks of IAV H5N1 in animals and humans . We utilized an H5-specific droplet digital RT-PCR test to quantify H5 RNA in wastewater in 40 states across the United States, and 1) examined the temporal association between outbreaks and wastewater detections and 2) utilized linear mixed models (LMM) to determine the relationship between measurements in wastewater and outbreak-related factors in the local area.  Results ....

Abstract The GreVac vaccine technology was created as a fast and flexible plug-and-play vaccine platform based on a 4th generation architecture of fully deleted (fd) helper virus independent (hi) adenoviral (Ad) vectors. For the initial proof-of-principle studies , we at Greffex had engineered an avian influenza vaccine , which delivered a transgene expression cassette for an avian influenza virus H5 hemagglutinin and N1 neuraminidase genes in a capsid of the common human Ad serotype 5 (Ad5). This vaccine proved highly immunogenic and protective in mice . These studies revealed that intramuscular (i.m.) delivery proved more efficient than subcutaneous (s.c.) or intranasal (i.n.) routes. In the human population, pre-exposure to the Ad5 virus is common. To minimize interference by pre-existing anti-Ad5 immunities, we created a new GreVac-based avian influenza vaccine, in which the fd Ad genome was packaged into a capsid of the rare human Ad serotype 6 (Ad6). We now report that at very lo...